HomeBusinessHealthcareEmbecta (EMBC) CEO On Treatments For Diabetes Patients
Embecta (EMBC) CEO On Treatments For Diabetes Patients

Embecta delivers treatment to diabetes patients and is a spin-off from Beckton, Dickinson, and Co. Embecta listed on the Nasdaq under the ticker symbol EMBC. The company is a leading producer of diabetes injection devices, manufacturing approximately 8 billion injection devices annually for about 30 million patients across more than 100 countries. CEO Dev Kurdikar discusses Embecta as a product innovator, industry leader with a global and serviceable need.

The Watch List

01 Apr 2022

ON AIR
9:30 pm
Next Gen Investing
replay
12:00 am
Fast Market
REPLAY
1:00 am
Trading 360
REPLAY
2:00 am
Next Gen Investing
REPLAY
education
3:00 am
Your First Trade
REPLAY
3:30 am
Trading 360
REPLAY
4:30 am
Next Gen Investing
REPLAY
education
5:30 am
Your First Trade
REPLAY
6:00 am
Fast Market
REPLAY
7:00 am
Futures
8:00 am
Morning Trade Live
10:00 am
Trading 360
11:00 am
Fast Market
12:00 pm
Next Gen Investing
1:00 pm
The Watch List
2:00 pm
Market On Close
education
3:30 pm
Your First Trade
4:00 pm
Trading 360
REPLAY
5:00 pm
Fast Market
REPLAY
6:00 pm
Next Gen Investing
REPLAY
education
7:00 pm
Your First Trade
REPLAY
7:30 pm
Trading 360
REPLAY
8:30 pm
Fast Market
REPLAY
ON AIR
9:30 pm
Next Gen Investing
REPLAY
education
10:30 pm
Your First Trade
REPLAY
11:00 pm
Trading 360
REPLAY

Get Market Minute

Daily insights for every investor

FOLLOW US